Exodus Point Capital Management, LP Invitae Corp Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.71 - $3.61 $98,039 - $206,972	-57,333 Reduced 52.56%	51,738 $96,000
Q3 2022 Nov 10, 2022	BUY	$1.9 - $8.63 $207,234 - $941,282	109,071 New	109,071 $268,000
Q2 2022 Aug 19, 2022	SELL	$2.13 - $9.01 $91,822 - $388,412	-43,109 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $270,724 - $672,069	43,109 New	43,109 $344,000
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $1.52 Million - $2.24 Million	-38,985 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $1.11 Million - $1.74 Million	38,985 New	38,985 $1.69 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.